PlainRecalls
FDA Drug Moderate Class II Terminated

fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL, (10 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-3

Reported: October 11, 2023 Initiated: September 21, 2023 #D-0011-2024

Product Description

fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL, (10 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-3

Reason for Recall

Lack of assurance of sterility:

Details

Units Affected
688 50 mL syringes
Distribution
Nationwide in the USA
Location
San Diego, CA

Frequently Asked Questions

What product was recalled?
fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL, (10 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-3. Recalled by Central Admixture Pharmacy Services Inc. Units affected: 688 50 mL syringes.
Why was this product recalled?
Lack of assurance of sterility:
Which agency issued this recall?
This recall was issued by the FDA Drug on October 11, 2023. Severity: Moderate. Recall number: D-0011-2024.